| 15 | | - | Section 1. Section 19a-127q of the general statutes is repealed and the |
|---|
| 16 | | - | following is substituted in lieu thereof (Effective October 1, 2024): |
|---|
| 17 | | - | (a) On and after January 1, 2019, any hospital licensed pursuant to |
|---|
| 18 | | - | chapter 368v or emergency medical services personnel, as defined in |
|---|
| 19 | | - | section 20-206jj, that treats a patient for an overdose of an opioid drug, |
|---|
| 20 | | - | as defined in section 20-14o, shall report such overdose to the |
|---|
| 21 | | - | Department of Public Health in a form and manner prescribed by the |
|---|
| 22 | | - | Commissioner of Public Health. |
|---|
| 23 | | - | (b) On and after January 1, 2020, any hospital licensed pursuant to |
|---|
| 24 | | - | chapter 368v that treats a patient for a nonfatal overdose of an opioid |
|---|
| 25 | | - | drug, as defined in section 20-14o, shall administer a mental health |
|---|
| 26 | | - | screening or assessment of the patient if medically appropriate, and |
|---|
| 27 | | - | provide the results of such screening or assessment to the patient if |
|---|
| 28 | | - | medically appropriate, or to the patient's parent, guardian or legal |
|---|
| 29 | | - | representative, as applicable, if medically appropriate. |
|---|
| 30 | | - | (c) On or before January 1, 2020, the Department of Public Health Substitute House Bill No. 5291 |
|---|
| 20 | + | Section 1. Section 19a-127q of the general statutes is repealed and the 1 |
|---|
| 21 | + | following is substituted in lieu thereof (Effective October 1, 2024): 2 |
|---|
| 22 | + | (a) On and after January 1, 2019, any hospital licensed pursuant to 3 |
|---|
| 23 | + | chapter 368v or emergency medical services personnel, as defined in 4 |
|---|
| 24 | + | section 20-206jj, that treats a patient for an overdose of an opioid drug, 5 |
|---|
| 25 | + | as defined in section 20-14o, shall report such overdose to the 6 |
|---|
| 26 | + | Department of Public Health in a form and manner prescribed by the 7 |
|---|
| 27 | + | Commissioner of Public Health. 8 |
|---|
| 28 | + | (b) On and after January 1, 2020, any hospital licensed pursuant to 9 |
|---|
| 29 | + | chapter 368v that treats a patient for a nonfatal overdose of an opioid 10 |
|---|
| 30 | + | drug, as defined in section 20-14o, shall administer a mental health 11 |
|---|
| 31 | + | screening or assessment of the patient if medically appropriate, and 12 |
|---|
| 32 | + | provide the results of such screening or assessment to the patient if 13 |
|---|
| 33 | + | medically appropriate, or to the patient's parent, guardian or legal 14 |
|---|
| 34 | + | representative, as applicable, if medically appropriate. 15 |
|---|
| 35 | + | (c) On or before January 1, 2020, the Department of Public Health 16 Substitute Bill No. 5291 |
|---|
| 34 | | - | shall provide the data reported pursuant to subsection (a) of this section |
|---|
| 35 | | - | to the municipal health department or district department of health that |
|---|
| 36 | | - | has jurisdiction over the location in which such overdose occurred, or, |
|---|
| 37 | | - | if such location is unknown, the location in which the hospital or |
|---|
| 38 | | - | emergency medical services personnel treated the patient, as the |
|---|
| 39 | | - | department, in its discretion, deems necessary to develop preventive |
|---|
| 40 | | - | initiatives. |
|---|
| 41 | | - | (d) (1) From January 1, 2025, until August 31, 2028, any hospital |
|---|
| 42 | | - | licensed pursuant to chapter 368v that treats a patient for a nonfatal |
|---|
| 43 | | - | overdose of an opioid drug, as defined in section 20-14o, shall |
|---|
| 44 | | - | administer, with the patient's consent, a toxicology screening of the |
|---|
| 45 | | - | patient, if medically appropriate. Such screening shall include, but need |
|---|
| 46 | | - | not be limited to, screening for opiates, opioids, benzodiazepines, |
|---|
| 47 | | - | cannabinoids, methadone, cocaine, gabapentin, xylazine and any other |
|---|
| 48 | | - | substance deemed appropriate by the commissioner. Any hospital that |
|---|
| 49 | | - | administers a toxicology screening pursuant to the provisions of this |
|---|
| 50 | | - | subsection shall report the screening results to the Department of Public |
|---|
| 51 | | - | Health in a form and manner prescribed by the commissioner. |
|---|
| 52 | | - | (2) On or before January 1, 2026, and annually thereafter, until |
|---|
| 53 | | - | January 1, 2029, the commissioner shall report, in accordance with the |
|---|
| 54 | | - | provisions of section 11-4a, to the joint standing committee of the |
|---|
| 55 | | - | General Assembly having cognizance of matters relating to public |
|---|
| 56 | | - | health regarding toxicology screening results obtained pursuant to the |
|---|
| 57 | | - | provisions of this subsection. Such report shall include, but need not be |
|---|
| 58 | | - | limited to, (A) the identification and analysis of any trends identified as |
|---|
| 59 | | - | a result of toxicology screening results obtained pursuant to the |
|---|
| 60 | | - | provisions of this subsection, (B) the identification of any benefits |
|---|
| 61 | | - | experienced by patients seeking emergency department care for |
|---|
| 62 | | - | nonfatal overdoses as a result of the toxicology screening results |
|---|
| 63 | | - | obtained pursuant to this subsection, and (C) a recommendation |
|---|
| 64 | | - | regarding whether toxicology screening reporting performed pursuant Substitute House Bill No. 5291 |
|---|
| 38 | + | LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2024HB-05291- |
|---|
| 39 | + | R01-HB.docx } |
|---|
| 40 | + | 2 of 3 |
|---|
| 66 | | - | Public Act No. 24-120 3 of 3 |
|---|
| 42 | + | shall provide the data reported pursuant to subsection (a) of this section 17 |
|---|
| 43 | + | to the municipal health department or district department of health that 18 |
|---|
| 44 | + | has jurisdiction over the location in which such overdose occurred, or, 19 |
|---|
| 45 | + | if such location is unknown, the location in which the hospital or 20 |
|---|
| 46 | + | emergency medical services personnel treated the patient, as the 21 |
|---|
| 47 | + | department, in its discretion, deems necessary to develop preventive 22 |
|---|
| 48 | + | initiatives. 23 |
|---|
| 49 | + | (d) (1) From January 1, 2025, until August 31, 2028, any hospital 24 |
|---|
| 50 | + | licensed pursuant to chapter 368v that treats a patient for a nonfatal 25 |
|---|
| 51 | + | overdose of an opioid drug, as defined in section 20-14o, shall 26 |
|---|
| 52 | + | administer, with the patient's consent, a toxicology screening of the 27 |
|---|
| 53 | + | patient, if medically appropriate. Such screening shall include, but need 28 |
|---|
| 54 | + | not be limited to, screening for opiates, opioids, benzodiazepines, 29 |
|---|
| 55 | + | cannabinoids, methadone, cocaine, gabapentin, xylazine and any other 30 |
|---|
| 56 | + | substance deemed appropriate by the commissioner. Any hospital that 31 |
|---|
| 57 | + | administers a toxicology screening pursuant to the provisions of this 32 |
|---|
| 58 | + | subsection shall report the screening results to the Department of Public 33 |
|---|
| 59 | + | Health in a form and manner prescribed by the commissioner. 34 |
|---|
| 60 | + | (2) On or before January 1, 2026, and annually thereafter, until 35 |
|---|
| 61 | + | January 1, 2029, the commissioner shall report, in accordance with the 36 |
|---|
| 62 | + | provisions of section 11-4a, to the joint standing committee of the 37 |
|---|
| 63 | + | General Assembly having cognizance of matters relating to public 38 |
|---|
| 64 | + | health regarding toxicology screening results obtained pursuant to the 39 |
|---|
| 65 | + | provisions of this subsection. Such report shall include, but need not be 40 |
|---|
| 66 | + | limited to, (A) the identification and analysis of any trends identified as 41 |
|---|
| 67 | + | a result of toxicology screening results obtained pursuant to the 42 |
|---|
| 68 | + | provisions of this subsection, (B) the identification of any benefits 43 |
|---|
| 69 | + | experienced by patients seeking emergency department care for 44 |
|---|
| 70 | + | nonfatal overdoses as a result of the toxicology screening results 45 |
|---|
| 71 | + | obtained pursuant to this subsection, and (C) a recommendation 46 |
|---|
| 72 | + | regarding whether toxicology screening reporting performed pursuant 47 |
|---|
| 73 | + | to this subsection should continue after August 31, 2028. 48 |
|---|
| 74 | + | [(d)] (e) Data reported to the Department of Public Health by a 49 Substitute Bill No. 5291 |
|---|
| 68 | | - | to this subsection should continue after August 31, 2028. |
|---|
| 69 | | - | [(d)] (e) Data reported to the Department of Public Health by a |
|---|
| 70 | | - | hospital or emergency medical services personnel pursuant to the |
|---|
| 71 | | - | provisions of this section shall at all times remain confidential pursuant |
|---|
| 72 | | - | to section 19a-25. |
|---|
| 76 | + | |
|---|
| 77 | + | LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2024HB-05291- |
|---|
| 78 | + | R01-HB.docx } |
|---|
| 79 | + | 3 of 3 |
|---|
| 80 | + | |
|---|
| 81 | + | hospital or emergency medical services personnel pursuant to the 50 |
|---|
| 82 | + | provisions of this section shall at all times remain confidential pursuant 51 |
|---|
| 83 | + | to section 19a-25. 52 |
|---|
| 84 | + | This act shall take effect as follows and shall amend the following |
|---|
| 85 | + | sections: |
|---|
| 86 | + | |
|---|
| 87 | + | Section 1 October 1, 2024 19a-127q |
|---|
| 88 | + | |
|---|
| 89 | + | PH Joint Favorable Subst. |
|---|